Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Vernalis (VNLS)

Vernalis Plc ADS (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VNLS
DateTimeSourceHeadlineSymbolCompany
11/12/200607:00PR Newswire (US)Vernalis plc Initiates a Phase I Trial of a Promising New Approach to Treating Obesity and Related Disorders - Including Type IINASDAQ:VNLS
21/11/200607:00PR Newswire (US)Vernalis plc to Present at the 18th Annual Piper Jaffray Healthcare Conference in New York on November 30, 2006NASDAQ:VNLSVernalis Plc ADS (MM)
20/11/200607:00PR Newswire (US)Vernalis plc Announces Progress on Its Oncology Hsp90 ProgrammeNASDAQ:VNLS
02/11/200607:00PR Newswire (US)Vernalis to Present at Cowen and Company 7th Annual Global Health Care ConferenceNASDAQ:VNLS
20/09/200614:31PR Newswire (US)Vernalis plc to Present at UBS Global Life Sciences Conference on September 26, 2006NASDAQ:VNLSVernalis Plc ADS (MM)
20/09/200611:30PR Newswire (US)Vernalis plc Announces FDA Acceptance for Filing of Frova(R) for Short-Term Prevention of Menstrual MigraineNASDAQ:VNLS
12/09/200608:00PR Newswire (US)Vernalis Plc: Interim Results for the Six Months Ended 30 June 2006NASDAQ:VNLS
19/07/200623:00PR Newswire (US)Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of MenNASDAQ:VNLSVernalis Plc ADS (MM)
19/07/200623:00PR Newswire (US)Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of MenNASDAQ:VNLS
19/06/200612:00PR Newswire (US)Vernalis plc to Present at Investor Conferences During June 2006NASDAQ:VNLSVernalis Plc ADS (MM)
17/05/200618:00PR Newswire (US)Vernalis plc [VNLS] CEO to Ring the NASDAQ Stock Market Closing BellNASDAQ:VNLSVernalis Plc ADS (MM)
15/05/200608:00PR Newswire (US)Vernalis plc to Ring the NASDAQ Closing Bell on May 18, 2006NASDAQ:VNLS
08/05/200608:00PR Newswire (US)Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual MigraineNASDAQ:VNLS
14/07/200423:50PR Newswire (US)Endo Licenses Rights from Vernalis to Market Acute Migraine Treatment Frova(TM)NASDAQ:VNLS
30/03/200413:00PR Newswire (US)Vernalis Regains Control of North American Rights To Frovatriptan From ElanNASDAQ:VNLSVernalis Plc ADS (MM)
30/03/200413:00PR Newswire (US)Vernalis plc: Preliminary Results for the Eight Months Ended 31 December 2003NASDAQ:VNLS
 Showing the most relevant articles for your search:NASDAQ:VNLS